Metachromatic leukodystrophy: clinical and enzymatic parameters

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Metachromatic leukodystrophy (MLD) is an inherited metabolic disorder.
• It involves the accumulation of sulfatide, a lipid component of myelin and neuronal membranes.
• The disease affects both children and adults, presenting a range of clinical manifestations.

Purpose of the Study:

• To review the clinical presentations of MLD.
• To discuss diagnostic aids for MLD.
• To explore genetic variations in arylsulfatase A and potential therapeutic strategies.

Main Methods:

• Literature review of MLD studies.
• Analysis of clinical case data.
• Examination of genetic and biochemical findings related to arylsulfatase A.

Main Results:

• MLD exhibits diverse clinical phenotypes.
• Diagnostic approaches include biochemical and genetic testing.
• Arylsulfatase A gene variations correlate with disease severity.

Conclusions:

• Understanding MLD's pathophysiology is crucial for diagnosis and management.
• Further research into arylsulfatase A and sulfatide metabolism may yield effective therapies.
• Genetic counseling and early diagnosis are important for affected families.